Prof. Marwa Galal El-Gazzar | Computational drug design | Research Excellence Award
Egyptian Atomic Energy Authority | Egypt
Prof. Marwa Galal El-Gazzar is a distinguished scholar in pharmaceutical chemistry Computational drug design with extensive experience in radiation-based drug research and development. She is affiliated with the National Centre for Radiation Research and Technology under the Egyptian Atomic Energy Authority, where she has progressed through academic and research leadership roles to head the Drug Radiation Research Department. Her expertise centers on pharmaceutical analysis, radiation sterilization of pharmaceuticals, radiolytic stability studies, drug formulation, and quality control of irradiated medicinal products.Her research focuses on evaluating the impact of ionizing radiation on drug molecules, investigating degradation pathways, and developing validated analytical methods to ensure safety, efficacy, and regulatory compliance of pharmaceutical products. She has contributed to advancing the application of radiation technology in drug sterilization, polymeric biomaterials, and pharmaceutical packaging systems. In addition, her work supports the development of innovative formulations and stability-indicating methods using advanced spectroscopic and chromatographic techniques.Through sustained research output, supervision of postgraduate students, and collaboration within multidisciplinary teams, she has strengthened the integration of radiation science and pharmaceutical chemistry. Her contributions play a significant role in enhancing drug safety standards and promoting the peaceful applications of radiation technology in healthcare and pharmaceutical industries.
1088
19
28
Citations
Documents
h-index
Featured Publications
Novel anticancer fused pyrazole derivatives as EGFR and VEGFR-2 dual TK inhibitors
– Frontiers in Chemistry, 2020 (Citations: 138)
Synthesis of novel pyrrole and pyrrolo [2,3-d] pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents
– Bioorganic & Medicinal Chemistry Letters, 2010 (Citations: 121)
Synthesis, characterization and anti-breast cancer activity of new 4-aminoantipyrine-based heterocycles
– International Journal of Molecular Sciences, 2014 (Citations: 72)
Anti-inflammatory, analgesic and COX-2 inhibitory activity of novel thiadiazoles in irradiated rats
– Journal of Photochemistry and Photobiology B: Biology, 2017 (Citations: 59)